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Tarantula venom glands produce a large variety of bioactive peptides. Here we present the identiﬁcation of venom components
obtained by sequencing clones isolated from a cDNA library prepared from the venom glands of the Chilean common tarantula,
Grammostola rosea. The cDNA sequences of about 1500 clones out of 4000 clones were analyzed after selection using several
criteria.Forty-eightnoveltoxin-likepeptides(GTx1toGTx7,andGTx-TCTPandGTx-CRISP)werepredictedfromthenucleotide
sequences. Among these peptides, twenty-four toxins are ICK motif peptides, eleven peptides are MIT1-like peptides, and seven
are ESTX-like peptides. Peptides similar to JZTX-64, aptotoxin, CRISP, or TCTP are also obtained. GTx3 series possess a cysteine
frameworkthatisconservedamongvertebrateMIT1,Bv8,prokineticins,andinvertebrateastakines.GTx-CRISPistheﬁrstCRISP-
like protein identiﬁed from the arthropod venom. Real-time PCR revealed that the transcripts for TCTP-like peptide are expressed
in both the pereopodal muscle and the venom gland. Furthermore, a unique peptide GTx7-1, whose signal and prepro sequences
are essentially identical to those of HaTx1, was obtained.
1.Introduction
Venomsarecomplexmixturesofmanydiﬀerentcomponents
proven to be useful tools for biochemical, physiological, and
pharmacological studies of ion channels and receptors. Tox-
ins that recognize ion channel subgroups are versatile tools
for channel studies and thus contribute to drug discovery [1,
2]. For example, a 25-amino-acid peptide isolated from the
marine ﬁsh-hunting cone snail Conus magus, ω-conotoxin-
MVIIA, blocks N-type voltage-dependent calcium channels.
In 2004, ziconotide, the synthetic version of ω-conotoxin-
MVIIA, was approved in the United States for the treatment
of chronic severe pain refractory to other current pain
medications.
About 40000 diﬀerent kinds of spiders are known at
present. Spider venoms contain peptide neurotoxins and are
expected to be a rich source of ion channel blockers [3–5].
Tarantulas, comprising more than 860 species, like all other
spiders are predators that feed on a variety of vertebrate
and invertebrate prey [6]. Tarantulas do not use webs for
capture but are well-equipped predators, possessing a variety
of venoms that target receptors in the nervous system,
probably with adaptation to a certain type of prey [7, 8].
Tarantula venom has been suggested to contain 1000 or
more peptide toxins [8]. Despite their diverse activities, these
toxins display only a few widely conserved structural motifs
that share remarkable similarities in their primary sequences
and tertiary structures [9–11]. In a similar fashion to the
evolution of snake toxins, several molecular scaﬀolds have
been used during the evolution of toxin “cocktails” in spider
venoms. Theselected genesareduplicated severaltimes, and,
while the core of each protein scaﬀold is conserved, the loops
and surfaces are altered through mutations [12]. We recently
found T-type voltage-dependent calcium channel blocker
from venom of Chilean common tarantula, Grammostola
rosea [13].2 International Journal of Peptides
Expressed sequence tags (ESTs) are short single-pass
sequence reads generated from either 5  or 3  end of cDNAs.
They provide a quick and inexpensive route for discovering
new genes and obtaining data on gene expression. The ESTs
approach has been used in several reports, because it is
a rapid and reliable method for gene discovery in gene-
ral, mainly in this case, related to secretory glands from ven-
omous animals [14–16].
In this paper, we focused on the tarantula toxins, and
by applying improved molecular biological techniques, we
revealed novel peptide sequences after ESTs techniques
applied to a cDNA library prepared from the Chilean com-
mon tarantula Grammostola rosea venom glands.
2.MaterialsandMethods
2.1. Animals and Venom Glands. Grammostola rosea taran-
tulas were obtained from a local pet supplier. The venom
glands were dissected from the chelicera and the pereopodal
muscles were from the prosoma using sharp forceps, frozen
immediately with liquid nitrogen, and then stored at −80◦C
until use.
2.2. cDNA Library Construction. Preparation of the venom
gland cDNA library was reported previously [13]. Brieﬂy, the
venom glands were dissected from 30 spiders, and total RNA
was extracted using TRIZOL reagent (Invitrogen, Carlsbad,
CA). Poly(A)+ RNA was prepared using Oligotex-dT30
Super (Takara Bio, Otsu, Japan). The ﬁrst-strand cDNAs
were synthesized from 2.5μgo fp o l y ( A ) + RNA using the
primer, VNXho(dT)30, which installs oligo dT and XhoI
sequences, by ReverTra Ace (Toyobo, Osaka, Japan) and
Superscript II (Invitrogen). The second strands were synthe-
sized with DNA polymerase I (Takara Bio), RNase H (Takara
Bio), and Escherichia coli D N Al i g a s e( T a k a r aB i o ) .Eco RI
adaptors(Clontech,PaloAlto,CA)wereligatedtothecDNAs
after both ends of the double-stranded cDNAs were ﬁlled
in with a DNA blunting kit (Takara Bio). The cDNAs were
then digested with XhoI and fractionated by 1.2% agarose
gel electrophoresis. DNA fragments with lengths of 0.8–
2.0kbp were eluted from dissected gel. The resulting DNA
fragments were ligated into EcoRI and XhoI restriction sites
of pSD64TRER [17]. E. coli XL1-Blue MRA (Agilent Tech-
nologies, Santa Clara, CA) was transformed with the plas-
mid. An aliquot of the cDNA library in E. coli was spread
onto LB agar plates containing 50μg/mL ampicillin, and the
p l a s m i dD N Aw a sp r e p a r e df o rt h eP C Rt e m p l a t e .
2.3.FingerprintingofClones. AnaliquotofcDNAlibrarywas
spread onto LB agar plates with ampicillin (50μg/mL) and
incubated at 37◦C overnight. Formed colonies were picked
up by automated colony picker (Microtec Nichion, Japan)
and inoculated into1mL of 2 × LB medium supplemented
with ampicillin (50μg/mL) in 96 deep-well plates and
incubatedat37◦Covernightwithvigorousshaking.Plasmids
were puriﬁed with an automated machine, BIOMEK2000,
(Beckman Coulter, USA) using MultiScreen-FB and -NA
(Millipore, USA) and eluted by 50μL TE solution, then
stored −20◦C until use. PCR was performed with an SP6
primer and a pSD64-speciﬁc reverse primer, SDA (5 -
TTATGTAGCTTAGAGACT-3 ), to amplify the inserts of
the cDNA library. Each PCR reaction mixture consists of
10pmol of the forward and reverse primers, 0.25 U EX
Taq polymerase (Takara Bio), 200mM each of dATP, dCTP,
d G T Pa n dd T T P ,2m MM g C l 2,P C Rb u ﬀer, and 1μLD N A
template. The reaction was performed in a thermal cycler
PTC-200 (MJ research, USA) for 30 cycles, each consisting
of denaturation at 94◦C for 30s, annealing at 42◦Cf o r4 5s ,
and polymerization at 72◦C for 1min, after the initial cycle
of 94◦C for 5min. At the end of all the cycles, samples were
maintained at 72◦C for 9min and then kept at 4◦C.
PCR reaction products were digested by DdeIr e s t r i c t i o n
enzyme at 37◦C and analyzed by electrophoresis in 3%
agarose/TBE gel, then visualized with ethidium bromide,
and digitized using gel documentation system, Gel Doc 1000
(Bio-Rad, USA). The band patterns of the digested PCR
products were clustered by the similarity using Molecular
Analyst Fingerprinting plus software (Bio-Rad).
2.4. Sequencing and Data Analysis. We manually selected
clones to be sequenced based on the ﬁngerprinting catego-
rization described previously. Single run DNA sequencings
were performed using an SP6 primer by a sequencer Model
ABI Prism 377 (Applied Biosystems, CA, USA) or performed
by Shimadzu. The obtained DNA sequences were translated
into amino acid sequences with all three frames using the
Vector NTI program (Invitrogen, USA). After translation
into three amino acid sequences, both protein and cDNA
sequences were stored into in-house database software,
KIROKU (World Fusion, Tokyo, Japan). Homology search
of translated protein sequences was performed at in-house
sequence database using the BLAST program. The pre-
diction of signal sequence was performed by SignalP 3.0 pro-
gram(http://www.cbs.dtu.dk/services/SignalP/). Amino acid
alignment and phylogenetic tree construction were perform-
ed using the MegAlign program by Clustal W and neighbor-
joining method (DNASTAR, Madison, USA).
2.5. PCR Cloning Based on the Signal Sequence of Toxins. We
synthesized oligonucleotide primers based on the conserved
initiation codon (ATG) and its juxtaposed sequences includ-
ing 5 -noncoding region and the signal sequences of the
GTxs(Table 1).UsingtheseprimersandanSDAprimer,PCR
ampliﬁcationswerecarriedoutwiththevenomglandscDNA
libraryasatemplate.Thereactionconditionswereessentially
the same as described in Section 2.3. Ampliﬁed fragments
were cloned into pCR 2.1-TOPO (Invitrogen). The full-
length nucleotide sequences of the clones were determined
by Hitachi Soft Co Ltd.
2.6. Quantiﬁcation of Tissue Expression of
GTx-TCTP and GTx-CRISP cDNAs
2.6.1. Cloning and Sequence Analysis of GTx-TCTP and
GTx-CRISP cDNAs. Single run sequencings of the venom
gland cDNA library revealed the ﬁrst half of GTx-TCTP
and GTx-CRISP cDNA including 5 -UTR region with startInternational Journal of Peptides 3
Table 1: Primers for PCR cloning.
Primers Nucleotide sequence Referred sequences
PC1 5 -TAARCGACAATGAAGAC-3  GTx1-11, 12, 14, 15, 16
PC2 5 -TTCGATAACATGAAGAC-3  GTx1-1, 2; GTx7-1
PC3 5 -AAAGCATGAAAACCTC-3  GTx1-3
PC4 5 -ACTCTAAAAATGAAGGC-3  G T x 1 - 4 ,5 ,7 ,8 ,9
PC5 5 -TCAGCAGAAATGAAGGC-3  GTx2-2, 3
PC6 5 -TCCATCATGAAGITNGC-3  G T x 3 - 4 ,5 ,6 ,7 ,8
PC7 5 -ATAACGATGAAGITINT-3  GTx5-1
PC8 5 -GCAGCCATGAAAICINT-3  GTx6-1
PC9 5 -GTTAAGATGAAITWYNC-3  GTx3-1, 2, 3
PC10 5 -GCAACGATGAGRTCINT-3  GTx4-1, 2
PC11 5 -GGAAACATGAGRAAINC-3  GTx1-13
Oligonucleotide primers are synthesized based on the conserved signal
sequences and the sequcences of 5–9 nucleotides upstream of initiation
codon of the GTxs indicated in the right column. Underline indicates
initiation codon, ATG. R: A/G; W: T/A; Y: T/C; N: A/T/C/G; I: inosine.
codon. To obtain the latter halves of GTx-TCTP and GTx-
CRISP cDNA including 3 -UTR region with the stop codon
from the cDNA library, PCRs were performed using the
gene-speciﬁc primers, 5 -TCAAGGATATGATTACTGGT-3 
for GTx-TCTP and 5 -AGGTGGGCTGAATCCTGT-3  for
GTx-CRISP,andanSDAprimers(seeSection 2.3)asforward
and reverse primers, respectively. The PCR was carried out
in a PTC-200 DNA thermal cycler (MJ Research, South San
Francisco, CA) using 30 cycles as follows: denaturation at
94◦C for 30s, annealing at 54◦Cf o r3 0s ,a n de x t e n s i o na t
72◦C for 1min using LA Taq polymerase (Takara Bio). The
ampliﬁed fragments were gel puriﬁed using QIAquick Gel
ExtractionKit(QIAGEN,Valencia,CA),subclonedintopCR
2.1-TOPO vector (Invitrogen), and sequenced using BigDye
Terminator Cycle Sequencing Ready Reaction Kit (version
3.1) and an ABI PRIZM 310 DNA sequencer (Applied
Biosystems, Foster City, CA).
2.6.2. Real Time PCR. The gene expressions of GTx-TCTP
and GTx-CRISP in the venom gland and pereopodal muscle
were quantiﬁed by real-time PCR. Tarantula G3PDH (GTx-
G3PDH) cDNA was cloned and used as an expression
control. Primers for the real-time PCR were designed using
Roche ProbeFinder version 2.45 (http://qpcr.probeﬁnder
.com/roche3.html). Primers for GTx-G3PDH were 5 -CAT-
GCTTGGCTAAGGGAGTAA-3  and 5 -TGTATTTGACAT-
CAATAAATGGATCA-3 ; primers for GTx-TCTP, 5 -CTC-
GGAGAATGGGAGACATT-3  and 5 -CATCTGCCTCCT-
CCTGAGAC-3 ; and primers for GTx-CRISP, 5 -GCACAA-
TTTCTTCAGGTCACG-3  and 5 -CAGCTCATTGCCAGC-
ATATC-3 . The venom glands and the pereopodal muscles
were stored at −80◦C and thawed in TRIZOL reagent (In-
vitrogen), homogenized, and directly subjected to total RNA
extraction according to manufacturer’s instructions. Total
RNA was reverse transcribed with PrimeScript RT reagent
Kit (Takara Bio). Real-time PCR mixtures were prepared
withSYBRPremixExTaqII(TakaraBio)accordingtomanu-
facturer’s instructions. The reaction and monitoring were
performed with Thermal Cycler Dice Real-Time System,
PT800 (Takara Bio) for 40 cycles of 2 step shuttle PCR (95◦C
for 5s, 60◦C for 30s).
3. Results and Discussion
We constructed a tarantula venom gland cDNA library from
2.5μgo fp o l y( A ) + RNA. The independency of the library
is about 4.4 × 105. We chose about 1500 clones out of 4000
clones based on the restriction-enzyme digestion patterns
determined by ﬁngerprinting software and sequenced by
single run sequencing from the upstream region of the
protein-coding sequence. After eliminating vector and low-
quality sequences, 869 high-quality ESTs were obtained. We
found that 284 clones (=32.7%) encode toxin-like sequences
among them. This ratio is comparable to the results from the
EST analysis of the venom glands of Theraphosidae family
tarantulas Chilobrachys jingzhao and Citharischius crawshayi,
in which 30.6% and 32.5% of analyzed clones encode
toxin-like sequences, respectively [16, 18, 19]. In the present
study, eight types of toxin-like scaﬀold were found mainly
based on a cysteine framework. It is noteworthy that 15
and 5 peptide scaﬀolds were reported from the EST studies
of the tarantulas Chilobrachys jingzhao and Citharischius
crawshayi,r e s p e c t i v e l y ,[ 16, 18, 19]. Thirty-four cDNAs
were additionally revealed by PCR cloning using primers
designed from the conserved initiation codon (ATG) and
its juxtaposed sequences including 5 -noncoding region and
the signal sequences.
We focused on unique 48 peptides belonging to eight
types of toxin-like scaﬀold. The resulted sequence analysis
and the database search are described here in after.
3.1. GTx1 Family, Long Loop ICK Motif Toxins; and GTx2
Family, Short Loop ICK Motif Toxins. Twenty long loop ICK
motif toxins and four short loop ICK motif toxins were
obtained (Figure 1(a)). In the mature sequences, the N-
terminal and the C-terminal sequence stretches separated
by cysteine residues are termed “loops” and numbered 1–6
from N- to C-terminus. The toxins with more than 6 amino
acids and the toxins with only three amino acids in the
loop 5 are designated as “long-loop” and “short-loop” ICK
toxinsgroup,respectively.Amongthesetoxins,wepreviously
showed that GTx1-15 preferentially block the currents of
the T-type voltage-dependent calcium channel Cav3.1 [13].
AmongtheGTx1andGTx2families,weidentiﬁedadditional
peptide cDNAs; those translated sequences are the same
as the previously reported ones, HaTx1 and 2, VSTx1
and 2, GsMTx4, GsAFI and II, GrTx1, and ω-GrTx SIA.
HaTx1 and 2 are well-known toxins that inhibit Kv2.1
and Kv4.2 voltage-gated potassium channels [20]. VSTx1
is a voltage sensor toxin from the spider Grammostola
rosea that inhibits KvAP, an archeabacterial voltage-activated
potassium channel whose X-ray structure has been reported
[21]. GsMTx4 is known as a toxin for stretch-activated
mechanosensitivechannels[22].GsAFIandIIhavebeenﬁrst
reported to be an analgesic and an antiarrhythmic peptides
from the venom of spider Grammostola rosea,r e s p e c t i v e l y
[23,24].GsAFI,GsAFII,andGrTx1havebeenshowntohave4 International Journal of Peptides
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Figure 1: Homology analysis of ICK motif toxins. (a) Homology alignment of ICKs. The putative signal sequences deduced by SignalP 3.0
server (http://www.cbs.dtu.dk/services/SignalP/) are indicated by dotted box. Signal sequences and prepro-sequences of GTx1-6, GTx1-24,
GTx2-4, GTx2-5, HnTx-IV, PaurTx3, TLTx1, CcoTx2, and VSTx1, 2, 3 are not determined. Mature toxin regions are indicated by closed box.
Conserved cysteine residues are indicated by closed boxes ﬁlled with gray color. (b) Phylogenetic tree of ICK toxins. Amino acid alignment
and phylogenetic tree construction were performed using the MegAlign program by Clustal W and neighbor-joining method (DNASTAR,
Madison, USA) based on the alignment (a) of mature peptides. A scale below the tree indicates the number of amino acid substitutions
per 100 residues for protein sequences. Known molecular targets are indicated following to the peptide names. Accession numbers: GTx1
and GTx2 families, AB200996-AB201024 and AB671302-AB671308; HaTx1, AB200991; HaTx2, AB200992; VSTx1, AB200994; GsAFI,
AB200995; GsAFII, AB612242; GrTx1, AB671300 and AB671301; ω-GrTx SIA, AB612243; GsMTx4, AB201020; PaurTx3, P84510; CcoTx2,
P84508; TLTx1, P83745; VSTx2, P0C2P4; VSTx3, P0C2P5.
similar blockade spectra against ion channels such as Nav1.1,
Nav1.2, Nav1.3, Nav1.4, Nav1.6, Nav1.7, and Kv11.1 [25, 26].
ω-GrTx SIA is reported to inhibit Cav2.1 and Cav2.2 voltage-
dependent calcium channels by modifying their voltage-
dependent gating [27, 28].
Asmentionedpreviously,HaTx1isknownasapotassium
channel gating modiﬁer but can inhibit sodium channels
at concentrations similar to those that modify the gat-
ing of potassium channels [29]. Recently, similar target
promiscuity and heterogeneous eﬀects of tarantula venomInternational Journal of Peptides 5
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Figure 2: Homology analysis of GTx3 series toxins. (a) Sequence alignment of GTx3 series and their related peptides. The putative signal
sequence deduced by SignalP 3.0 server (http://www.cbs.dtu.dk/services/SignalP/) is indicated by dotted box. Signal sequence of MIT1
is not determined. Conserved cysteine residues are indicated by closed boxes ﬁlled with gray color. AVIT N-terminals of Prokineticin1,
Prokineticin2, MIT1, and Bv8 are indicated closed boxes. (b) Phylogenetic tree of GTx3 series and related peptides. Amino acid alignment
and phylogenetic tree construction were performed using the MegAlign program by Clustal W and neighbor-joining method (DNASTAR)
based on the alignment (a) of mature peptides. A scale below the tree indicates the number of amino acid substitutions per 100 residues
for protein sequences. Accession numbers: GTx3 series, AB201025-AB201034 and AB671309-AB671311; Bv8, AF168790; Prokineticin
1, AF333024; Prokineticin 2, AAH96695; MIT1, P25687; HWTX-XIVa1, ABY77690; ACTX-Hvf17, P81803; Pacifastacus leniusculus (Pl)
astakine1, AY787656; Pl astakine2a, EF568370; Acanthoscurria gomesiana (Ag) astakine1, DR447331; Ag astakine2, DR445103; Rhipicephalus
appendiculatus (Ra) astakine2, CD794853; Ixodes scapularis (Is) astakine2, EW845057; Amblyomma variegatum (Av) astakine2, BM292046;
Dysdera erythrina (De) astakine2, CV178181.
voltage-sensor toxins are discussed including GsAFI and
II, GrTx1 described previously [25, 30]. We also suggest
similar target promiscuity; that is, a toxin family including
GsAFII, GsMTx2, PaTx2, and ProTx-II could aﬀect several
types of ion channels such as stretch-activated channels
and the voltage-dependent sodium, potassium, and calcium
channels [13]. Figure 1(b) shows phylogenetic tree of GTx1,
GTx2, and several ICK toxins. The correlations between
the peptide groups and their target molecules are not clear.
Vega discussed the pharmacological diversiﬁcation of ICK
motif toxin by phylogenetic analysis of 171 homologous
ICK toxins using Bayesian inference [31]. Although the
relationship between clusters is not satisfactorily solved, sev-
eral trustable monophyletic groups appear from the analy-
sis. The main conclusion from the tree is a plausible lin-
age-speciﬁc process of paralogous diversiﬁcation from
several independent recruiting events. Further investigation
is needed to elucidate the relationships between evolutional
processes and the pharmacological diversiﬁcation and target
promiscuity of ICK toxins.
3.2.GTx3Series:SimilartoMambaIntestinalToxin1(MIT1),
Bv8/Prokineticins, and Invertebrate Astakines. Eleven tox-
ins similar to MIT1, Bv8/prokineticins, and invertebrate
astakines were identiﬁed (Figure 2). Bv8, prokineticins, and
MIT1 consist in a group known as AVIT family due to their
N-terminal residues A-V-I-T [32]. MIT1 shows contractile
eﬀects on longitudinal ileal muscle and distal colon [33]. The
solution structure of MIT1 was determined at a resolution
of 0.5 ˚ A and revealed a new type of folding for venom tox-
ins similar to that of colipase, a protein involved in fatty
acid digestion [34]. Bv8 is bioactive peptide found from
frog skin to induce hyperalgesic eﬀects [35] and belongs
to a family of secretory proteins (Bv8-prokineticin family)6 International Journal of Peptides
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Figure 3: Sequence alignments of GTx4 (a), GTx5 (b), and GTx6 (c) series. The putative signal sequence deduced by SignalP 3.0 server
(http://www.cbs.dtu.dk/services/SignalP/)isindicatedbydottedbox.SignalsequencesofGTx4-7andsignalsequencesandprepro-sequences
of BsTx, ESTX, and Ba1 are not determined. Mature toxin regions are indicated by closed box in (a) and (b). Conserved cysteine residues
are indicated by closed boxes ﬁlled with gray color. Accession numbers: GTx4 series, AB201035-AB201036 and AB671312-AB671317; BsTx,
P49265; ESTX, P61509; Ba1, P85497; JZTX-48, EU233840; GTx5-1 and GTx5-2, AB201037 and AB683255; JZTX-64, EU233914; HWTX-
XVIIIc1, EU195231; HNTX-XVIII-7, GU293118; LSTX-R1, EU926143; GTx6-1, AB201038; HWTX-XVa2, EU195236; JZTX-72, EU233926;
Aptotoxin I, P49267.
whose orthologues have been conserved throughout evo-
lution from invertebrates to human. The prokineticins (PK1
and PK2, also known as endocrine gland vascular endo-
thelialgrowthfactor(EG-VEGF)andBv8,resp.)areinvolved
in signaling through two highly homologous G-protein-
coupledreceptors,PKR1andPKR2[36].Bv8/PK2isupregu-
lated in inﬂammatory granulocytes and modulates inﬂam-
matory pain [37]. Blockade of PKRs might represent a
therapeutic strategy in acute and inﬂammatory pains [38].
Vertebrate PKs are released from damaged tissues and act
as regulators of inﬂammatory responses, including recruit-
ment of new blood cells [39]. Invertebrate astakine, a homo-
logue to vertebrate PKs, was ﬁrst identiﬁed in Pacifastacus
leniusculus and was found to be necessary for new hemocyte
synthesis and release [40]. Although astakines lack the N-
terminal AVIT motif, they are designated as prokineticin
domain-containing proteins based on their hematopoietic
function. No astakine or prokineticin homologue is present
in the genome of Drosophila or other dipterans, so far.
Figure 2(a) shows that the cysteine frameworks of GTx3
series peptides, vertebrate PKs, invertebrate astakines, and
several peptide toxins are well conserved. ACTX-Hvf17 from
Australian funnel-web spiders lacks the N-terminal AVIT
motif and did not aﬀect smooth muscle contractility or
block PK1-induced contractions in guinea pig ileum [5].
PRTx16C0 from Brazilian Amazonian armed spider (acces-
sion no. P83893) is nontoxic to mice and insects. The eﬀect
of HWTX-XIVa1 from Chinese bird spider is unknown [41].
Phyogenetic tree shows that GTx3-4 to GTx3-9, invertebrate
astakines, vertebrate prokineticin-related proteins, and spi-
dertoxinsformlargefamily,whileGTx3-1toGTx3-3,GTx3-
10andGTx3-11formadistantlyrelatedgroup(Figure 2(b)).
For the spider proteins containing prokineticin domain
(ACTX-Hvf17,PRTx16C0,HWTX-XIVa1,andGTx3series),
furtherinvestigationisneededtorevealtheirbiologicalfunc-
tions, especially their eﬀects on the hematopoietic system.
3.3.GTx4,5,6Series:SimilartoOtherToxins. GTx4seriesare
similar to ESTX [42], BsTx [43], JZTX-47, 48 [16], and Ba1,
2[ 44]( Figure 3(a)). They are characterized as conserved six
cysteine residues. A clear diﬀerence between the sequences
of GTx4 series and that of the reported ones is the length of
the loop 3. ESTX is puriﬁed from tarantula Eurypelma cali-
fornicum venom and BsTx is from Mexican red nee tarantula
Brachypelma smithii venom. The eﬀects of ESTX and BsTx
are not clear. Ba1 and Ba2 are insecticidal peptides puriﬁed
from theraphosid spider Brachypelma albiceps venom and an
N M R - b a s e d3 Dm o d e lo fB a 2i sp r o p o s e d[ 44].
GTx5-1 and GTx5-2 are similar to JZTX-64 from
Chilobrachys jingzhao [16], HWTX-XVIIIc1 from Ornithoc-
tonus huwena [41], HNTX-XVIII-7 from Ornithoctonus
hainana [45], and LSTX-R1 from Lycosa singoriensis [46]
(Figure 3(b)). These toxins are identiﬁed by large-scale
venomic strategy and the target molecules are unknown.
GTx6-1 is very similar to HWTX-XVa2 from Haplopelma
schmidti [41] and JZTX-72 from Chilobrachys guangxiensis
[16], and similar to aptotoxin I [47], as well (Figure 3(c)).
As mentioned previously, insecticidal eﬀects were
reported for Ba1, Ba2, and aptotoxin; however, targetInternational Journal of Peptides 7
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Figure 4: Sequence alignment of GTx-TCTP (a) and GTx-CRISP (b) families. The putative signal sequence deduced by SignalP 3.0 server
(http://www.cbs.dtu.dk/services/SignalP/) is indicated by dotted box. Conserved cysteine residues are indicated by closed boxes ﬁlled with
gray color. (c) The results of real-time PCR. G3PDH is equally expressed in the pereopodal muscle (PM) and the venom gland (VG). GTx-
CRISP transcript is predominantly expressed in the venom gland. The GTx-CRISP transcript in the PM is one-400th of that in the VG.
GTx-TCTP transcript is expressed in both the pereopodal muscle and the venom gland. The GTx-TCTP transcript in the PM is one-13th
of that in the VG. Results were conﬁrmed in triplicate experiments. Accession numbers: GTx-TCTP, AB201040; HumanTCTP, NM 003295;
Bombyx mori (Bm) TCTP, NM 001044107; Dermacentor andersoni (Da) HRF, DQ009480; GTx-CRISP, AB201041; Pseudecin (Harpegnathos
saltator), EFN80524; Human-CRISP1, NM 001205220; Helothermine, U13619; Ablomin, AF384218.
molecules of GTx4, 5, 6, and their homologues are not yet
known.
3.4. GTx-TCTP and GTx-CRISP. We also obtained one
translationally controlled tumor protein- (TCTP-) like pep-
tide (Figure 4(a)) and one cysteine-rich secretory protein-
(CRISP-) like peptide (Figure 4(b)).
TCTP was ﬁrst identiﬁed as a growth-related tumor
protein whose synthesis is controlled mainly at the transla-
tional level [48]. This protein has been recognized as a cell8 International Journal of Peptides
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Figure 5: Sequence alignment of GTx7-1. The putative signal sequence deduced by SignalP 3.0 server (http://www.cbs.dtu.dk/services/
SignalP/) is indicated by dotted box. Mature toxin regions are indicated by closed box. Note that the signal sequences and prepro-sequences
are almost same but mature GTx7-1 diﬀers from GTx1-1 and HaTx1. Accession number: GTx7-1, AB201039.
cycle-dependent, tubulin-binding protein having calcium-
bindingsites[49].Inadditiontothisgrowth-relatedfunction
as a cytosolic protein, TCTP is now known to act as a
secretory protein. TCTP has been uniquely characterized as
an IgE-dependent histamine-releasing factor [50].
CRISPsarefoundinavarietyoforganisms,suchasmam-
mals, reptiles, amphibians, and secernentea. The ﬁrst discov-
ered CRISP (acidic epididymis glycoprotein, also known as
protein D/E or CRISP-1) was isolated from mammalian epi-
didymis [51–53]. Two other mammalian CRISPs have been
isolated and characterized: CRISP-2 (testis-speciﬁc protein
1) [54] and CRISP-3 (speciﬁc granule protein of 28kDa)
[55].VenomicCRISPswereidentiﬁedmainlyfromlizardand
snake, so far. Helothermine, a CRISP family toxin, is discov-
ered from the lizard of the Central America [56]a n d
blocks voltage-gated calcium and potassium channels and
ryanodine receptors [57]. Ablomin is a 25-kDa protein
isolated from the venom of the Japanese Mamushi snake
(Agkistrodon blomhoﬃ)[ 58]. Ablomin blocks contraction
o fr a tt a i la r t e r i a ls m o o t hm u s c l ee l i c i t e db yh i g hK +-in-
duced depolarization. In insects, it is revealed that an ant
(Harpegnathos saltator) genome contains a CRISP family
protein, Pseudecin [59]. GTx-CRISP is the ﬁrst CRISP
protein identiﬁed from the arthropod venom.
To compare the expression levels of the transcripts for
GTx-CRISP and GTx-TCTP between the venom gland and
the pereopodal muscle, we conducted real-time PCR. The
results indicate that transcript of GTx-TCTP was expressed
in both the tissues, while that of GTx-CRISP was predom-
inantly expressed in the venom gland (Figure 4(c)). It is
tempting to assume that GTx-TCTP acts as both growth-
related cytosolic protein and secretory proteins, an IgE-de-
pendent histamine-releasing factor. Further investigation is
needed to elucidate the bifunctional feature of GTx-TCTP.
3.5. Other Toxins. The predicted mature portion of the
peptide GTx7-1, 21 amino acid residues with two cysteine
residues, has a unique sequence (Figure 5). It has no amino
acid sequence homology with any other peptide registered
in the public database up to now. On the other hand, the
preprotoxin sequence of GTx7-1 is very similar to GTx1
family. GTx7-1 slightly and transiently inhibited the con-
traction of guinea pig right atrial preparation at high con-
centration (13.2μM) (Japan patent publication number:
2008-271800).
3.6. Biochemical and Biomedical Applications of Peptide Tox-
ins. Natural peptide toxins contribute to biochemical, phy-
siological, and pharmacological studies especially on cel-
lular/neuronal signal transduction. Furthermore, some of
the peptides and its derivatives have been developed as
potential therapeutic agents. Their utility is based on an un-
precedented selectivity in targeting speciﬁc molecular forms,
such as subgroups of ion channels and subtypes of receptors,
and even speciﬁc substates of channel functions.
There are principally two approaches to access to the
peptide with some aimed function/property. One is to
screen such a peptide from the venom/secreta or tissue
extracts, and the other is to screen from cDNA libraries
followed by expression and functional assays. Recently, we
have developed a new approach by utilizing natural toxin
scaﬀold combined with in vitro selection technology. We ﬁrst
constructedarandompeptidelibrarybasedonathree-ﬁnger
(3F) neurotoxin scaﬀold. From the 3F peptide library, in
vitro selections targeting to interleukin-6 receptor were per-
formed, and ﬁnally peptide ligands with the antagonist-like
and the agonist-like property were generated [60]. Variety of
toxin scaﬀolds are available up to now, and still unknown
scaﬀolds might be revealed by genomic approach for the
venom/secretionglands.Thenewinvitroevolutionapproach
will be further applied to diﬀerent toxin scaﬀolds including
ICK motifs and also will be directed to diﬀerent targets, such
as biomarkers for diagnosis or drug development, or target
cells for imaging and drug delivery, and so forth.
4. Conclusions
We have challenged to reveal a peptide repertoire contained
in the venom gland of tarantula Grammostola rosea. In the
previousreport,weidentiﬁedseveralnovelpeptidesfromthe
spider venom by both proteomic and genomic approaches
and reported their modulation activities toward calcium
channels [13]. Here in this study, we further presented 48
novel peptides grouped as GTx1 to GTx7, and TCTP- and
CRISP-like peptides, and compared the sequences with the
homologues. GTx1 and 2 series are mostly homologous to
ion channel blockers. GTx3 series are related to the peptides
that modulate cell growth and/or cell signaling via GPCRs
such as vertebrate prokineticins and invertebrate astakines.
GTx-CRISP is the ﬁrst identiﬁed arthropod venom CRISP.
GTx-TCTP is expressed in both the venom gland and the
pereopodal muscle and assumed to act as both TCTP and
HRF. Biochemical and physiological characterizations of
these peptides are under investigation. Furthermore, we are
nowapplyingthenextgenerationsequencingtototallyreveal
the transcripts of the tarantula venom gland.
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